StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Johnson & Johnson (JNJ) PT Raised to $196 at Raymond James
April 20, 2022 5:56 AM
Raymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $196.00 (from $195.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS View
Analyst PT Change
Next Articles
Johnson & Johnson (JNJ) PT Raised to $205 at Credit Suisse
April 20, 2022 6:51 AM
Johnson & Johnson (JNJ) PT Raised to $210 at Citi
April 19, 2022 3:11 PM
Form 8-K JOHNSON & JOHNSON For: Apr 19
April 19, 2022 7:57 AM
Johnson & Johnson (JNJ) Shares Dip After Revenue Miss, Suspended COVID Vaccine Sales Guidance; Results Seen as 'Mixed'
April 19, 2022 7:37 AM
Alkermes (ALKS) Commences Arbitration Related to License Agreements with Janssen Pharmaceutica
April 19, 2022 7:32 AM
J&J pulls COVID vaccine sales forecast due to low demand, supply glut
April 19, 2022 6:28 AM
Johnson & Johnson (JNJ) Tops Q1 EPS by 6c, Updates FY Guidance
April 19, 2022 6:28 AM
Johnson & Johnson Reports Q1 2022 Results
April 19, 2022 6:25 AM